June 5, 2020 / 10:11 AM / a month ago

BRIEF-Abbvie, Harbour Biomed, Utrecht University And Erasmus Medical Center Collaborate To Develop Covid-19 Antibody Therapy

June 5 (Reuters) - Abbvie Inc:

* ABBVIE, HARBOUR BIOMED, UTRECHT UNIVERSITY AND ERASMUS MEDICAL CENTER ANNOUNCE COLLABORATION TO DEVELOP MONOCLONAL ANTIBODY THERAPY TO PREVENT AND TREAT COVID-19

* ABBVIE INC - CO, HBM, UU AND EMC ANNOUNCED THEY HAVE ENTERED COLLABORATION TO DEVELOP A NOVEL ANTIBODY THERAPEUTIC TO PREVENT AND TREAT COVID-19

* ABBVIE - TO SUPPORT UU, EMC, HBM THROUGH PRECLINICAL ACTIVITIES, WHILE UNDERTAKING PREPARATIONS FOR LATER STAGE PRECLINICAL, CLINICAL DEVELOPMENT WORK

* ABBVIE INC - TO GET OPTION TO EXCLUSIVELY LICENSE ANTIBODY FROM THREE PARTIES FOR THERAPEUTIC CLINICAL DEVELOPMENT, COMMERCIALIZATION WORLDWIDE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below